Canntab Therapeutics (OTC:CTABF) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Canntab Therapeutics (CTABF) operate in?

Canntab Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCEM.

Canntab Therapeutics Stock (OTC: CTABF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 5.78K
Day Range	- - -
52 Wk Range	0.00 - 0.01
Market Cap	$3.89K
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	999.99

Recent News

Canopy Growth & Other Cannabis Operators Just Made Some Key Executive Changes You Should Know About

As Benzinga Cannabis Capital Conference returns on September 13-14 to Chicago, gathering top CEOs, investors and leaders in the industry, let's scroll through the latest leadership changes within the space.

Jelena Martinovic

Canntab Therapeutics Signs Affiliate Agreement With OnPharm-United

Canntab Therapeutics Limited (OTCQB: CTABF) (CSE: PILL.CN) (FRA: TBF1.F) has entered into an affiliate agreement with OnPharm-United, a 600 plus network of independent pharmacy owners throughout the province of Ontario.

Vuk Zdinjak

Canntab Therapeutics Teams Up With First Nations Growers To Support Indigenous Peoples In Canada Amid Opiate & Illicit Drug Crisis

Canntab Therapeutics Limited (CSE:PILL) (OTCQB: CTABF) (FRA:TBF1) has announced a strategic planning collaboration and commercial partnership to create an Indigenous Opiate and Illicit Drug Crisis Plan lead by First Nations community leader chief Adam Pawis of the Shawanaga First Nation.

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About

Sector

Healthcare

Industry

N/A

Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ont...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Canntab Therapeutics (CTABF) stock?

You can purchase shares of Canntab Therapeutics (OTCEM:CTABF) through any online brokerage.

View our list of the best stock brokerages

Who are Canntab Therapeutics (CTABF) competitors?

There are no as such competitors for Canntab Therapeutics.

What is the forecast, or price target, for Canntab Therapeutics (CTABF) stock?

There is no analysis for Canntab Therapeutics to provide a consensus price target.

What is the current price for Canntab Therapeutics (CTABF)?

The stock price for Canntab Therapeutics (OTCEM: CTABF) is $0.0001 last updated September 6, 2024 at 3:37 PM EDT.

Does Canntab Therapeutics (CTABF) pay a dividend?

There are no upcoming dividends for Canntab Therapeutics.

When is Canntab Therapeutics (OTCEM:CTABF) reporting earnings?

Canntab Therapeutics does not have any upcoming earnings scheduled.

Is Canntab Therapeutics (CTABF) going to split?

There is no upcoming split for Canntab Therapeutics.

What sector and industry does Canntab Therapeutics (CTABF) operate in?

Canntab Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCEM.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now